Univest
Univest
  • Markets

Sudeep Pharma Ltd. (SUDEEPPHRM) Share Price Hits Fresh 52-Week High

  • August 5, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
Sudeep Pharma Ltd. Share Price

Sudeep Pharma Ltd. Share Price surged to Rs 917.85, marking a 5.57% rise and a fresh 52-week high. The company’s market cap stands at Rs 9,810.15 crore.

Sudeep Pharma Ltd. Share Price reached a new 52-week high today, closing at Rs 917.85, a significant increase of 5.57% from the previous close of Rs 869.45. This surge brought the company’s market capitalisation to Rs 9,810.15 crore. The stock opened at Rs 816.55 and reached a high of Rs 919.4 during the day, indicating strong investor interest. The fresh 52-week high highlights the stock’s recent momentum, although the data does not specify a company-specific catalyst for this rise. Investors and analysts are closely monitoring Sudeep Pharma Ltd. Share Price for further developments.

Sudeep Pharma Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 917.85
Previous Close Rs 869.45
Today's Change +Rs 48.4 (+5.57%)
Day Open Rs 816.55
Fresh 52-Week High Rs 919.4
Day Low Rs 801
Current Volume 67,583
Turnover Rs 6.2 crore
Market Capitalisation Rs 9,810.15 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 917.85. versus the previous close of Rs 869.45, a rise of 5.57%. The stock opened at Rs 816.55, reached Rs 919.4, touched Rs 801. Reported volume was 67,583.

Today, Sudeep Pharma Ltd. Share Price opened at Rs 816.55 and reached a high of Rs 919.4, setting a fresh 52-week high. The stock closed at Rs 917.85, up by Rs 48.4 or 5.57% from the previous close of Rs 869.45. The day’s low was Rs 801, and the turnover was Rs 6.2 crore with a volume of 67,583 shares. This price action reflects strong buying interest, pushing the stock to new heights. The significant increase in price and volume suggests heightened investor activity.

Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 9,810.15 crore
P/E Ratio 30.21x
P/B Ratio 0.44x
ROE -2.89%
ROCE -0.26%

Sudeep Pharma Ltd. was valued at a P/E ratio of 30.21x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric Value
Sector Healthcare
Benchmark Scope same sector
Company P/E Ratio 30.21x
Benchmark Median P/E 21.71x
Benchmark Average P/E 71.67x
Benchmark P/E Range 0x to 3,385.56x
Company P/B Ratio 0.44x
Benchmark Median P/B 1.9x
Company ROE -2.89%
Benchmark Median ROE 10.75%
Company ROCE -0.26%
Benchmark Median ROCE 13.29%
Company Market Capitalisation Rs 9,810.15 crore
Benchmark Median Market Cap Rs 136.63 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 30.21x, which is above the benchmark median of 21.71x, a difference of +39.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Dishman Carbogen Amcis Ltd. DCAL 2,945.17 30.21 0.44 -2.89 -0.26
Kwality Pharmaceuticals Ltd. KPL 2,652.68 39.86 8.11 28.21 26.35
Beta Drugs Ltd. BETA 2,608.51 63.2 10 18.65 22.17
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,457.9 32.25 6.65 -2.6 16.92
Sai Parenteral's Ltd. SAIPARENT 2,451.51 164.6 3.04 13.9 12.97

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 30.21x compared with the displayed peer median of 39.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 9,810.15 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Sudeep Pharma Ltd.

  • Strong price action with a fresh 52-week high at Rs 917.85.
  • Moderate P/E ratio compared to sector median.
  • Significantly larger market cap than peers.
  • Negative profitability metrics indicating potential challenges.
  • Operates in the diverse Healthcare sector with 198 companies.

About Sudeep Pharma Ltd.

Sudeep Pharma Ltd. is a prominent player in the Healthcare sector, focusing on pharmaceuticals and related products. The company has established itself with a significant market presence, reflected in its large market capitalisation. Despite its size, Sudeep Pharma faces challenges in profitability, as indicated by its negative ROE and ROCE. The company’s valuation metrics suggest potential, but investors should consider the broader sector context and peer performance when evaluating its prospects.

Track Sudeep Pharma Ltd. Share Price on Univest

Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Sudeep Pharma Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed about the latest developments and market trends.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the current share price of Sudeep Pharma Ltd.?

Ans. The current share price of Sudeep Pharma Ltd. is Rs 917.85, marking a 5.57% increase from the previous close. This price also represents a fresh 52-week high for the company.

What is Sudeep Pharma Ltd.'s market capitalisation?

Ans. Sudeep Pharma Ltd.'s market capitalisation is Rs 9,810.15 crore, making it a significant player in the Healthcare sector compared to its peers. The company operates in the Healthcare sector. Its P/E ratio is 30.21x.

How does Sudeep Pharma Ltd.'s P/E ratio compare to the sector?

Ans. Sudeep Pharma Ltd.'s P/E ratio is 30.21, which is above the sector median of 21.71 but below the average of 71.67, indicating a moderate valuation. The company trades at a P/E ratio of 30.21x.

What are the profitability metrics for Sudeep Pharma Ltd.?

Ans. Sudeep Pharma Ltd. has a negative ROE of -2.89% and a negative ROCE of -0.26%, suggesting challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%.

How does Sudeep Pharma Ltd. compare to its peers?

Ans. Sudeep Pharma Ltd. has a larger market cap than peers like Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd., but its profitability metrics are less favorable. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.

What is the P/B ratio of Sudeep Pharma Ltd.?

Ans. Sudeep Pharma Ltd. has a P/B ratio of 0.44, significantly lower than the sector median of 1.9, indicating potential undervaluation relative to its book value. The company trades at a P/E ratio of 30.21x.

Where can I track Sudeep Pharma Ltd. Share Price?

Ans. You can track Sudeep Pharma Ltd. Share Price, technical indicators, and market insights on Univest for the latest updates and analysis. The stock moved 5.57% during the session. The intraday range extended from Rs 801 to Rs 919.4.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply